NWPF

News ArchivesRead News

Brain Inflammation Linked to Greater Complications in Parkinson's Disease

Wednesday August 28, 2013

Kathleen Lees

Science World Report - A recent study looks at brain inflammation and the increasing problem involving fluid in the brain's cortex and complications with Parkinson's disease.

According to researcher Lena Brudin of Michigan State University's College of Human Medicine who was part of a research team that measured inflammatory markers involving cerebrospinal fluid samples of Parkinson's patients and members of the control group, inflammation caused significantly more problems when relating to the disease.

"The degree of neuroinflammation was significantly associated with more severe depression, fatigue and cognitive impairment even after controlling for factors such as age, gender and disease duration," Brundin said, an associate professor in the college and a researcher with the Van Andel Institute, via a press release. "By investigating associations between inflammatory markers and non-motor symptoms we hope to gain further insights into this area, which in turn could lead to new treatment options."

Researchers have long believed that brain inflammation is the suspected cause of Parkinson's disease and can specifically cause depression, fatigue and cognitive impairment. Recent research also suggests that inflammation could drive cell death and prevent the development of new drugs that may halt the progression of the health issue.

As Parkinson's is the second most common degenerative disorder of the central nervous system, many causes surrounding the disorder are not yet fully understood.

The study looked at 87 Parkinson's patients who were enrolled between 2008 and 2012. The control group consisted of 37 individuals who were recruited and underwent a physical exam and routine blood screen. Researcher also looked at the following markers, according to the study: C-reactive protein, interleukin-6, tumor necrosis factor-alpha, eotaxin, interferon gamma-induced protein-10, monocyte chemotactic protein-1 and macrophage inflammatory protein 1-B.

More information regarding the study can be found via the journal Brain, Behavior and Immunity.

Lees, K. (28 Aug 2013). Science World Report. Brain Inflammation Linked to Greater Complications in Parkinson's Disease. www.scienceworldreport.com

Recent News

Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 18 - Fighting Parkinson's disease through dance
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show